{"title":"The maturation of speech structure in psychosis is resistant to formal education.","authors":"Natália Bezerra Mota, Mariano Sigman, Guillermo Cecchi, Mauro Copelli, Sidarta Ribeiro","doi":"10.1038/s41537-018-0067-3","DOIUrl":"https://doi.org/10.1038/s41537-018-0067-3","url":null,"abstract":"<p><p>Discourse varies widely with age, level of education, and psychiatric state. Word graphs have been recently shown to provide behavioral markers of formal thought disorders in psychosis (e.g., disorganized flow of ideas) and to track literacy acquisition in children with typical development. Here we report that a graph-theoretical computational analysis of verbal reports from subjects spanning 6 decades of age and 2 decades of education reveals asymptotic changes over time that depend more on education than age. In typical subjects, short-range recurrence and lexical diversity stabilize after elementary school, whereas graph size and long-range recurrence only steady after high school. Short-range recurrence decreases towards random levels, while lexical diversity, long-range recurrence, and graph size increase away from near-randomness towards a plateau in educated adults. Subjects with psychosis do not show similar dynamics, presenting at adulthood a children-like discourse structure. Typical subjects increase the range of word recurrence over school years, but the same feature in subjects with psychosis resists education.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"25"},"PeriodicalIF":5.4,"publicationDate":"2018-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0067-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36811403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-11-28DOI: 10.1038/s41537-018-0065-5
Gaelle Keromnes, Tom Motillon, Nathalie Coulon, Alain Berthoz, Foucaud Du Boisgueheneuc, Moritz Wehrmann, Brice Martin, Bérangère Thirioux, Olivier Bonnot, Romain Ridereau, Eric Bellissant, Dominique Drapier, David Levoyer, Nemat Jaafari, Sylvie Tordjman
{"title":"Self-other recognition impairments in individuals with schizophrenia: a new experimental paradigm using a double mirror.","authors":"Gaelle Keromnes, Tom Motillon, Nathalie Coulon, Alain Berthoz, Foucaud Du Boisgueheneuc, Moritz Wehrmann, Brice Martin, Bérangère Thirioux, Olivier Bonnot, Romain Ridereau, Eric Bellissant, Dominique Drapier, David Levoyer, Nemat Jaafari, Sylvie Tordjman","doi":"10.1038/s41537-018-0065-5","DOIUrl":"10.1038/s41537-018-0065-5","url":null,"abstract":"<p><p>Clinical observations suggest early self-consciousness disturbances in schizophrenia. A double mirror combining the images of two individuals sitting on each side of the mirror was used to study self-other differentiation in 12 individuals with early onset schizophrenia (EOS) and 15 individuals with adult onset schizophrenia (AOS) compared to 27 typically developing controls (TDC) matched on age and sex. The effects of intermodal sensory perception (visual-tactile and visual-kinesthetic) on self-other recognition were also studied. The results showed that EOS and AOS individuals, independently of age and schizophrenia severity, were centered on their own image compared to TDC, with both significant earlier self-recognition and delayed other-recognition during the visual recognition task. In addition, there was no significant effect of intermodal sensory stimulation on self-other recognition in EOS and AOS patients, whereas self-centered functioning was significantly increased by visual-tactile stimulation and decreased by visual-kinesthetic stimulation in TDC. The findings suggest that self-other recognition impairments might be a possible endophenotypic trait of schizophrenia.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"24"},"PeriodicalIF":5.4,"publicationDate":"2018-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36729518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-11-19DOI: 10.1038/s41537-018-0066-4
Florian J Raabe, Sabrina Galinski, Sergi Papiol, Peter G Falkai, Andrea Schmitt, Moritz J Rossner
{"title":"Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems.","authors":"Florian J Raabe, Sabrina Galinski, Sergi Papiol, Peter G Falkai, Andrea Schmitt, Moritz J Rossner","doi":"10.1038/s41537-018-0066-4","DOIUrl":"https://doi.org/10.1038/s41537-018-0066-4","url":null,"abstract":"<p><p>Postmortem studies in patients with schizophrenia (SCZ) have revealed deficits in myelination, abnormalities in myelin gene expression and altered numbers of oligodendrocytes in the brain. However, gaining mechanistic insight into oligodendrocyte (OL) dysfunction and its contribution to SCZ has been challenging because of technical hurdles. The advent of individual patient-derived human-induced pluripotent stem cells (hiPSCs), combined with the generation of in principle any neuronal and glial cell type, including OLs and oligodendrocyte precursor cells (OPCs), holds great potential for understanding the molecular basis of the aetiopathogenesis of genetically complex psychiatric diseases such as SCZ and could pave the way towards personalized medicine. The development of neuronal and glial co-culture systems now appears to enable the in vitro study of SCZ-relevant neurobiological endophenotypes, including OL dysfunction and myelination, with unprecedented construct validity. Nonetheless, the meaningful stratification of patients before the subsequent functional analyses of patient-derived cell systems still represents an important bottleneck. Here, to improve the predictive power of ex vivo disease modelling we propose using hiPSC technology to focus on representatives of patient subgroups stratified for genomic and/or phenomic features and neurobiological cell systems. Therefore, this review will outline the evidence for the involvement of OPCs/OLs in SCZ in the context of their proposed functions, including myelination and axon support, the implications for hiPSC-based cellular disease modelling and potential strategies for patient selection.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"23"},"PeriodicalIF":5.4,"publicationDate":"2018-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0066-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36695096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-10-25DOI: 10.1038/s41537-018-0064-6
Igne Sinkeviciute, Marieke Begemann, Merel Prikken, Bob Oranje, Erik Johnsen, Wan U Lei, Kenneth Hugdahl, Rune A Kroken, Carina Rau, Jolien D Jacobs, Silvia Mattaroccia, Iris E Sommer
{"title":"Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis.","authors":"Igne Sinkeviciute, Marieke Begemann, Merel Prikken, Bob Oranje, Erik Johnsen, Wan U Lei, Kenneth Hugdahl, Rune A Kroken, Carina Rau, Jolien D Jacobs, Silvia Mattaroccia, Iris E Sommer","doi":"10.1038/s41537-018-0064-6","DOIUrl":"https://doi.org/10.1038/s41537-018-0064-6","url":null,"abstract":"<p><p>Cognitive impairment is a core feature of schizophrenia, which is predictive for functional outcomes and is, therefore, a treatment target in itself. Yet, literature on efficacy of different pharmaco-therapeutic options is inconsistent. This quantitative review provides an overview of studies that investigated potential cognitive enhancers in schizophrenia. We included pharmacological agents, which target different neurotransmitter systems and evaluated their efficacy on overall cognitive functioning and seven separate cognitive domains. In total, 93 studies with 5630 patients were included. Cognitive enhancers, when combined across all different neurotransmitter systems, which act on a large number of different mechanisms, showed a significant (yet small) positive effect size of 0.10 (k = 51, p = 0.023; 95% CI = 0.01 to 0.18) on overall cognition. Cognitive enhancers were not superior to placebo for separate cognitive domains. When analyzing each neurotransmitter system separately, agents acting predominantly on the glutamatergic system showed a small significant effect on overall cognition (k = 29, Hedges' g = 0.19, p = 0.01), as well as on working memory (k = 20, Hedges' g = 0.13, p = 0.04). A sub-analysis of cholinesterase inhibitors (ChEI) showed a small effect on working memory (k = 6, Hedges' g = 0.26, p = 0.03). Other sub-analyses were positively nonsignificant, which may partly be due to the low number of studies we could include per neurotransmitter system. Overall, this meta-analysis showed few favorable effects of cognitive enhancers for patients with schizophrenia, partly due to lack of power. There is a lack of studies involving agents acting on other than glutamatergic and cholinergic systems, especially of those targeting the dopaminergic system.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"22"},"PeriodicalIF":5.4,"publicationDate":"2018-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0064-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36618110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-10-15DOI: 10.1038/s41537-018-0063-7
Richard Newton, Alice Rouleau, Anna-Greta Nylander, Jean-Yves Loze, Henrike K Resemann, Sara Steeves, Benedicto Crespo-Facorro
{"title":"Diverse definitions of the early course of schizophrenia-a targeted literature review.","authors":"Richard Newton, Alice Rouleau, Anna-Greta Nylander, Jean-Yves Loze, Henrike K Resemann, Sara Steeves, Benedicto Crespo-Facorro","doi":"10.1038/s41537-018-0063-7","DOIUrl":"https://doi.org/10.1038/s41537-018-0063-7","url":null,"abstract":"<p><p>Schizophrenia is a debilitating psychiatric disorder and patients experience significant comorbidity, especially cognitive and psychosocial deficits, already at the onset of disease. Previous research suggests that treatment during the earlier stages of disease reduces disease burden, and that a longer time of untreated psychosis has a negative impact on treatment outcomes. A targeted literature review was conducted to gain insight into the definitions currently used to describe patients with a recent diagnosis of schizophrenia in the early course of disease ('early' schizophrenia). A total of 483 relevant English-language publications of clinical guidelines and studies were identified for inclusion after searches of MEDLINE, MEDLINE In-Process, relevant clinical trial databases and Google for records published between January 2005 and October 2015. The extracted data revealed a wide variety of terminology and definitions used to describe patients with 'early' or 'recent-onset' schizophrenia, with no apparent consensus. The most commonly used criteria to define patients with early schizophrenia included experience of their first episode of schizophrenia or disease duration of less than 1, 2 or 5 years. These varied definitions likely result in substantial disparities of patient populations between studies and variable population heterogeneity. Better agreement on the definition of early schizophrenia could aid interpretation and comparison of studies in this patient population and consensus on definitions should allow for better identification and management of schizophrenia patients in the early course of their disease.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"21"},"PeriodicalIF":5.4,"publicationDate":"2018-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0063-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36587735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-10-03DOI: 10.1038/s41537-018-0062-8
Sophie K Kirchner, Astrid Roeh, Jana Nolden, Alkomiet Hasan
{"title":"Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review.","authors":"Sophie K Kirchner, Astrid Roeh, Jana Nolden, Alkomiet Hasan","doi":"10.1038/s41537-018-0062-8","DOIUrl":"https://doi.org/10.1038/s41537-018-0062-8","url":null,"abstract":"<p><p>The main objective of this review was to evaluate studies on the diagnosis, treatment, and course of schizotypal personality disorder and to provide a clinical guidance on the basis of that evaluation. A systematic search in the PubMed/MEDLINE databases was conducted. Two independent reviewers extracted and assessed the quality of the data. A total of 54 studies were eligible for inclusion: 18 were on diagnostic instruments; 22, on pharmacological treatment; 3, on psychotherapy; and 13, on the longitudinal course of the disease. We identified several suitable and reliable questionnaires for screening (PDQ-4+ and SPQ) and diagnosing (SIDP, SIDP-R, and SCID-II) schizotypal personality disorder. Second-generation antipsychotics (mainly risperidone) were the most often studied drug class and were described as beneficial. Studies on the longitudinal course described a moderate remission rate and possible conversion rates to other schizophrenia spectrum disorders. Because of the heterogeneity of the studies and the small sample sizes, it is not yet possible to make evidence-based recommendations for treatment. This is a systematic evaluation of diagnostic instruments and treatment studies in schizotypal personality disorder. We conclude that there is currently only limited evidence on which to base treatment decisions in this disorder. Larger interventional trials are needed to provide the data for evidence-based recommendations.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"20"},"PeriodicalIF":5.4,"publicationDate":"2018-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0062-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36597329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-09-19DOI: 10.1038/s41537-018-0061-9
Derya Çokal, Gabriel Sevilla, William Stephen Jones, Vitor Zimmerer, Felicity Deamer, Maggie Douglas, Helen Spencer, Douglas Turkington, Nicol Ferrier, Rosemary Varley, Stuart Watson, Wolfram Hinzen
{"title":"The language profile of formal thought disorder.","authors":"Derya Çokal, Gabriel Sevilla, William Stephen Jones, Vitor Zimmerer, Felicity Deamer, Maggie Douglas, Helen Spencer, Douglas Turkington, Nicol Ferrier, Rosemary Varley, Stuart Watson, Wolfram Hinzen","doi":"10.1038/s41537-018-0061-9","DOIUrl":"https://doi.org/10.1038/s41537-018-0061-9","url":null,"abstract":"<p><p>Formal thought disorder (FTD) is clinically manifested as disorganized speech, but there have been only few investigations of its linguistic properties. We examined how disturbance of thought may relate to the referential function of language as expressed in the use of noun phrases (NPs) and the complexity of sentence structures. We used a comic strip description task to elicit language samples from 30 participants with schizophrenia (SZ), 15 with moderate or severe FTD (SZ + FTD), and 15 minimal or no FTD (SZ-FTD), as well as 15 first-degree relatives of people with SZ (FDRs) and 15 neurotypical controls (NC). We predicted that anomalies in the normal referential use of NPs, sub-divided into definite and indefinite NPs, would identify FTD; and also that FTD would also be linked to reduced linguistic complexity as specifically measured by the number of embedded clauses and of grammatical dependents. Participants with SZ + FTD produced more referential anomalies than NC and produced the fewest definite NPs, while FDRs produced the most and thus also differed from NC. When referential anomalies were classed according to the NP type in which they occurred, the SZ + FTD group produced more anomalies in definite NPs than NC. Syntactic errors did not distinguish groups, but the SZ + FTD group exhibited significantly less syntactic complexity than non-SZ groups. Exploratory regression analyses suggested that production of definite NPs distinguished the two SZ groups. These results demonstrate that FTD can be identified in specific grammatical patterns which provide new targets for detection, intervention, and neurobiological studies.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"18"},"PeriodicalIF":5.4,"publicationDate":"2018-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0061-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36506739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-09-17DOI: 10.1038/s41537-018-0060-x
Wei Cheng, Lena Palaniyappan, Mingli Li, Keith M Kendrick, Jie Zhang, Qiang Luo, Zening Liu, Rongjun Yu, Wei Deng, Qiang Wang, Xiaohong Ma, Wanjun Guo, Susan Francis, Peter Liddle, Andrew R Mayer, Gunter Schumann, Tao Li, Jianfeng Feng
{"title":"Addendum: Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry.","authors":"Wei Cheng, Lena Palaniyappan, Mingli Li, Keith M Kendrick, Jie Zhang, Qiang Luo, Zening Liu, Rongjun Yu, Wei Deng, Qiang Wang, Xiaohong Ma, Wanjun Guo, Susan Francis, Peter Liddle, Andrew R Mayer, Gunter Schumann, Tao Li, Jianfeng Feng","doi":"10.1038/s41537-018-0060-x","DOIUrl":"https://doi.org/10.1038/s41537-018-0060-x","url":null,"abstract":"","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"19"},"PeriodicalIF":5.4,"publicationDate":"2018-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0060-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36499847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-09-03DOI: 10.1038/s41537-018-0059-3
David M Bortz, Anthony A Grace
{"title":"Medial septum activation produces opposite effects on dopamine neuron activity in the ventral tegmental area and substantia nigra in MAM vs. normal rats.","authors":"David M Bortz, Anthony A Grace","doi":"10.1038/s41537-018-0059-3","DOIUrl":"10.1038/s41537-018-0059-3","url":null,"abstract":"<p><p>The medial septum (MS) differentially impacts midbrain dopamine (DA) neuron activity via the ventral hippocampus, a region implicated in DA-related disorders. However, whether MS regulation of ventral tegmental area (VTA) and substantia nigra pars compacta (SNc) is disrupted in a developmental disruption model of schizophrenia is unknown. Male Sprague-Dawley rats were exposed at gestational day 17 to methylazoxymethanol (MAM) or saline. As adults, NMDA (0.75 µg/0.2 µL) was infused into the MS, and either DA neuron activity in the VTA and SNc (7-9 anesthetized rats per group) or amphetamine-induced hyperlocomotion (AIH, 11-13 rats per group) was measured. MS activation produced a 58% increase in the number of spontaneously active DA neurons in VTA and a 37% decrease in SNc in saline rats. However, MS activation produced opposite effects on DA population activity in MAM rats, decreasing VTA DA activity by 51% and increasing SNc DA activity by 47%. MS activation also increased AIH by 113% in MAM rats, opposite of what is seen in intact rats. The effect in behavioral output may be due to disrupted GABAergic regulation of SNc as bicuculline infusion into vSub, which selectively prevented the MS activation-induced decrease in SNc DA activity in intact rats, prevented the increase in AIH and SNc DA activity in MAM rats. These findings demonstrate that the regulation of midbrain DA neurons by the MS is disrupted in this well-validated animal model, suggesting that it could be a potential locus for pharmacological intervention in disorders such as schizophrenia.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"17"},"PeriodicalIF":5.7,"publicationDate":"2018-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36456179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NPJ SchizophreniaPub Date : 2018-08-21DOI: 10.1038/s41537-018-0058-4
M P Boks, L C Houtepen, Z Xu, Y He, G Ursini, A X Maihofer, P Rajarajan, Q Yu, H Xu, Y Wu, S Wang, J P Shi, H E Hulshoff Pol, E Strengman, B P F Rutten, A E Jaffe, J E Kleinman, D G Baker, E M Hol, S Akbarian, C M Nievergelt, L D De Witte, C H Vinkers, D R Weinberger, J Yu, R S Kahn
{"title":"Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia.","authors":"M P Boks, L C Houtepen, Z Xu, Y He, G Ursini, A X Maihofer, P Rajarajan, Q Yu, H Xu, Y Wu, S Wang, J P Shi, H E Hulshoff Pol, E Strengman, B P F Rutten, A E Jaffe, J E Kleinman, D G Baker, E M Hol, S Akbarian, C M Nievergelt, L D De Witte, C H Vinkers, D R Weinberger, J Yu, R S Kahn","doi":"10.1038/s41537-018-0058-4","DOIUrl":"https://doi.org/10.1038/s41537-018-0058-4","url":null,"abstract":"<p><p>Epigenetic changes may account for the doubled risk to develop schizophrenia in individuals exposed to famine in utero. We therefore investigated DNA methylation in a unique sample of patients and healthy individuals conceived during the great famine in China. Subsequently, we examined two case-control samples without famine exposure in whole blood and brain tissue. To shed light on the causality of the relation between famine exposure and DNA methylation, we exposed human fibroblasts to nutritional deprivation. In the famine-exposed schizophrenia patients, we found significant hypermethylation of the dual specificity phosphatase 22 (DUSP22) gene promoter (Chr6:291687-293285) (N = 153, p = 0.01). In this sample, DUSP22 methylation was also significantly higher in patients independent of famine exposure (p = 0.025), suggesting that hypermethylation of DUSP22 is also more generally involved in schizophrenia risk. Similarly, DUSP22 methylation was also higher in two separate case-control samples not exposed to famine using DNA from whole blood (N = 64, p = 0.03) and postmortem brains (N = 214, p = 0.007). DUSP22 methylation showed strong genetic regulation across chromosomes by a region on chromosome 16 which was consistent with new 3D genome interaction data. The presence of a direct link between famine and DUSP22 transcription was supported by data from cultured human fibroblasts that showed increased methylation (p = 0.048) and expression (p = 0.019) in response to nutritional deprivation (N = 10). These results highlight an epigenetic locus that is genetically regulated across chromosomes and that is involved in the response to early-life exposure to famine and that is relevant for a major psychiatric disorder.</p>","PeriodicalId":19328,"journal":{"name":"NPJ Schizophrenia","volume":"4 1","pages":"16"},"PeriodicalIF":5.4,"publicationDate":"2018-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1038/s41537-018-0058-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36416209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}